Video
Video course abdominal ultrasound
Flow pattern of the right liver vein
Author: Prof. Dr. Christoph F. Dietrich, Caritas Krankenhaus Bad Mergentheim.
© 2015 Falk Foundation e.V., Freiburg. All rights reserved.
Please switch on your loudspeakers!
Link to Falk Mediacenter:
http://media.drfalkpharma.de/index.php?id=127&L=1
Link to the video directly:
http://media.drfalkpharma.de/fileadmin/media/12_Liver_Flow_pattern_of_the_right_liver_vein_ENG.mp4
Preview images:
580 x 350 pixels (with arrow)
http://www.drfalkpharma.de/fileadmin/media/newsletter/Logos/Sono_Clip12_580P.jpg
580 x 350 pixels (without arrow)
http://www.drfalkpharma.de/fileadmin/media/newsletter/Logos/Sono_Clip12_580.jpg
Bowel
Text:
Monteleone G et al, N Engl J Med. 2015;372(12):1104–13
New therapeutic approach for Crohn’s disease: Mongersen, an oral SMAD7 antisense oligonucleotide, induces clinical remission in > 60% of patients in a phase II trial.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20372#29244
Text:
Vande Casteele N et al, Gastroenterology. 2015;148(7):1320–9.e3
Continued concentration-based dosing of infliximab is not superior to clinically based dosing for maintaining remission of inflammatory bowel disease.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20372#c29245
Text:
Wright EK et al, Gastroenterology. 2015;148(5):938–47.e1
Fecal calprotectin concentrations correlate well with postoperative recurrences of Crohn’s disease.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20372#c29246
Liver
Biliary Tracts
Text:
Nelson DR et al, Hepatology. 2015;61(4):1127–35
Hepatitis C: A 12-week course of daclatasvir plus sofosbuvir leads to viral clearance in 96% of patients with genotype 3 infection without cirrhosis.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20372#c29247
Text:
Hirschfield GM et al, Gastroenterology. 2015;148(4):751–61.e8
Primary biliary cirrhosis: Obeticholic acid is efficient in patients with prior inadequate response to ursodeoxycholic acid. Pruritus is, however, a principal adverse event.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20372#c29248
Text:
Schmidt ML et al, Gastroenterology. 2015;148(5):967–77.e2
Liver cirrhosis: Decreasing mortality in the US indicates an improved clinical management of complications of liver cirrhosis. In contrast, the impact of sepsis associated with cirrhosis is growing.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20372#c29249
Oesophagus
Stomach
Duodenum
Text:
Abraham NS et al, BMJ. 2015;350:h1857
Comparable risk of gastrointestinal bleeding with dabigatran, rivaroxaban and warfarin in a population-based cohort study.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20372#c29250
Text:
Bratlie SO et al, Clin Gastroenterol Hepatol. 2015;13(6):1068–74.e2
Endoscopic surveillance of Barrett’s esophagus: Multiple band imaging is not superior to standard white light endoscopy in the detection of dysplasia, but requires the collection of significantly fewer biopsies.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20372#c29251
Text:
Witteman BPL et al, Am J Gastroenterol. 2015;110(4):531–42
Gastroesophageal reflux disease: Transoral incisionless fundoplication does not result in long-term reflux control.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20372#c29252
Pancreas
Text:
Ngamruengphong S et al, Gut. 2015;64(7):1105–10
Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancer.
Link:
http://www.drfalkpharma.de/index.php?L=1&id=20372#c29253
Current Falk literature:
NEW
The microbiota and intestinal diseases
Authors: B.J. Campbell, J.M. Rhodes
(38 pages)
S19e
Picture:
PDF: